Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00984308 · ClinicalTrials.gov registry record · Phase 2
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
A Phase 2 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 2
- Development phase
- 225
- Enrollment target
NCT00984308: Completed Phase 2 study, sponsored by VA Office of Research and Development.
NCT00984308 is a Phase 2 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 225 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (69% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00984308, a Phase 2 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 225 participants
- Enrollment target
Study Summary
Sleep apnea is common among Veterans with cerebrovascular disease (stroke or transient ischemic attack \[TIA\]), leads to hypertension, and is associated with recurrent stroke and death. Although continuous positive airway pressure (CPAP) safely treats sleep apnea, few Veterans with cerebrovascular disease are diagnosed with sleep apnea or offered treatment.
Primary Outcome
The number of patients with a diagnosis of sleep apnea
Interventions
- PROCEDURE CPAP Therapy for Newly Diagnosed Obstructive Sleep Apnea (OSA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2008-12-23 |
| Est. Completion | 2011-09-30 |
| Phase | Phase 2 |
What the finished NCT00984308 record still lists
NCT00984308 is an interventional study that assigns participants to a tested intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (69% higher).
The record links to 0 conditions, and to 1 intervention - of which CPAP Therapy for Newly Diagnosed Obstructive Sleep Apnea (OSA) is the first listed.
NCT00984308 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00984308 about?
NCT00984308 is a clinical study titled "Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease". Sleep apnea is common among Veterans with cerebrovascular disease (stroke or transient ischemic attack \[TIA\]), leads to hypertension, and is associated with recurrent stroke and death. Although continuous positive airway pressure (CPAP) safely treats sleep apnea, few Veterans with cerebrovascular ...
What is the current status of trial NCT00984308?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 225 participants. The study started on 2008-12-23. Estimated completion is 2011-09-30.
What interventions are being tested in trial NCT00984308?
The interventions under investigation include: CPAP Therapy for Newly Diagnosed Obstructive Sleep Apnea (OSA) (PROCEDURE).
Who is sponsoring clinical trial NCT00984308?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00984308's enrollment target sits among peer trials
225 267th of 2000 higher than 1,732 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03955445 · 225 participants · Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
- NCT04054310 · 225 participants · NA
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- NCT04480554 · 225 participants · Phase 2
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
- NCT04888104 · 225 participants
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI